TG Therapeutics
TGTX
TGTX
101 hedge funds and large institutions have $422M invested in TG Therapeutics in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 35 increasing their positions, 25 reducing their positions, and 11 closing their positions.
Holders
101
Holders Change
-5
Holders Change %
-4.72%
% of All Funds
2.52%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.05%
New
7
Increased
35
Reduced
25
Closed
11
Calls
$9.23M
Puts
$5.16M
Net Calls
+$4.07M
Net Calls Change
+$4.03M
Top Buyers
1 |
BM
1
Bridger Management
New York
|
$62.7M |
2 |
2
State Street
Boston,
Massachusetts
|
$38.5M |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$26.8M |
4 |
4
Charles Schwab
San Francisco,
California
|
$2.89M |
5 |
CCI
5
Columbus Circle Investors
|
$18.2M |